Free Trial

RBC Life Sciences (RBCL) News Today

RBC Life Sciences logo

RBCL Latest News

Edwards Lifesciences (EW) Receives a Buy from RBC Capital
RBC Capital Sticks to Their Buy Rating for Edwards Lifesciences (EW)
RBC Capital Sticks to Their Hold Rating for Wave Life Sciences (WVE)
Wave Life Sciences price target raised to $15 from $7 at RBC Capital
RBC Life Science and Technology (0P0001TAGA)
RBC Capital Reaffirms Their Hold Rating on BioMarin Pharmaceutical (BMRN)
RBC Capital Reaffirms Their Buy Rating on Edwards Lifesciences (EW)
RBC Mortgage Rates 2024
RBCL RBC Life Sciences, Inc.
RBC Capital Keeps Their Buy Rating on Illumina (ILMN)
PGA Tour Enterprises board meets at RBC Heritage
RBC's Helima Croft talks looming OPEC+ meeting
RBC Capital Sticks to Its Buy Rating for Telus (TU)
RBC Stock: Should You Invest in February 2023?
RBC Capital Reaffirms Their Buy Rating on Microsoft (MSFT)
HSBC to sell Canadian business to RBC for $10 bln
RBC Capital Keeps Their Buy Rating on Gilead Sciences (GILD)
Get RBC Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for RBCL and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RBCL Media Mentions By Week

RBCL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RBCL
News Sentiment

0.00

0.93

Average
Medical
News Sentiment

RBCL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RBCL Articles
This Week

0

0

RBCL Articles
Average Week

Get the Latest News and Ratings for RBCL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for RBC Life Sciences and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (OTCMKTS:RBCL) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners